Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Predictors of Increased Eosinophilic Esophagitis (EoE) Disease Activity After Proton Pump Inhibitor Therapy — B. Wisner (2024) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Predictors of Increased Eosinophilic Esophagitis (EoE) Disease Activity After Proton Pump Inhibitor Therapy
Shared by
Peter J Barnes
Imperial College London
Predictors of Increased Eosinophilic Esophagitis (EoE) Disease Activity After Proton Pump Inhibitor Therapy
Article
2024
en
Authors
+4 more
BW
B. Wisner
DM
Derek Meyers
AS
Aaron Smith
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2021
Increased Prevalence of Eosinophilic Esophagitis (EoE) in Children with Inflammatory Bowel Disease (IBD)
Ryan Eid
,
Christina Mounzer
,
Michael Mendoza
,
Jeremy P. Middleton
,
Peter J Barnes
,
Emily C. McGowan
Article
2026
Prevalence and Predictors of Eosinophilic Esophagitis (EoE) Among Children with Severe Asthma
Erica Licari
,
L Borish
,
Soutik Ghosal
,
Cameron Griffiths
,
Peter J Barnes
,
Ariana Greenwell
,
Jeremy P. Middleton
,
W. Gerald Teague
,
Emily C. McGowan
Article
2025
Prevalence and Predictors of Eosinophilic Esophagitis (EoE) in Children with Severe Asthma
Elisa Licari
,
Soutik Ghosal
,
Larry Borish
,
Peter J Barnes
,
Gerald Teague
,
Emily C. McGowan
Article
2022
Co-localization of Immunoglobulin G4 (IgG4) and milk proteins is associated with Eosinophilic Esophagitis (EoE) disease activity
Rung‐chi Li
,
Jonathan Medernach
,
Elaine F. Etter
,
Larry Borish
,
Hong‐Ru Chen
,
Jeffrey M. Wilson
,
Peter J Barnes
,
Thomas A.E. Platts‐Mills
,
Bryan G. Sauer
Article
2021
Serum food-specific Immunoglobulin G4 (sIgG4) levels decrease after steroid treatment in Eosinophilic Esophagitis (EoE)
Rung‐chi Li
,
Behnam Keshavarz
,
Jeffrey M. Wilson
,
Lisa J. Workman
,
Peter J Barnes
,
Bryan G. Sauer
,
Thomas A.E. Platts‐Mills
,
Emily C. McGowan
Discussion(0)
No comments yet. Be the first to comment.